Thomas Hurwich

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice President, Controller Abbvie Inc Jan. 2, 2013 - Feb. 28, 2017
Thomas Hurwich's trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
122.27
Quantity 60,406 -23.5%
Value US$2,749,992
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
140.98
Quantity 63,821 +43.8%
Value US$2,973,469
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
218.31
Quantity 40,128 +7.4%
Value US$287,244
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
62.00
Quantity 3,100 -4.8%
Value US$192,200
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
63.60
Quantity 100 -0.2%
Value US$6,360
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
63.59
Quantity 5,900 -8.7%
Value US$375,181
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
55.25
Quantity 1,444 -2.3%
Value US$79,777
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
66.00
Quantity 6,200 -8.3%
Value US$409,200
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
60.57
Quantity 1,185 -1.7%
Value US$71,777
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
67.82
Quantity 100 -0.2%
Value US$6,782
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
67.81
Quantity 1,400 -2.2%
Value US$94,936
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2017-03-02 2017-02-28
US Abbvie Inc (ABBV)
S Sale
60,406 -23.5%
122.27
US$2,749,992 		60,406 -23.5% 122.27 US$2,749,992
2017-03-02 2017-02-28
US Abbvie Inc (ABBV)
S Sale
63,821 +43.8%
140.98
US$2,973,469 		63,821 +43.8% 140.98 US$2,973,469
2017-03-02 2017-02-28
US Abbvie Inc (ABBV)
S Sale
40,128 +7.4%
218.31
US$287,244 		40,128 +7.4% 218.31 US$287,244
2016-11-18 2016-11-16
US Abbvie Inc (ABBV)
S Sale
3,100 -4.8%
62.00
US$192,200 		3,100 -4.8% 62.00 US$192,200
2016-05-12 2016-05-10
US Abbvie Inc (ABBV)
S Sale
100 -0.2%
63.60
US$6,360 		100 -0.2% 63.60 US$6,360
2016-05-12 2016-05-10
US Abbvie Inc (ABBV)
S Sale
5,900 -8.7%
63.59
US$375,181 		5,900 -8.7% 63.59 US$375,181
2016-03-02 2016-02-29
US Abbvie Inc (ABBV)
S Sale
1,444 -2.3%
55.25
US$79,777 		1,444 -2.3% 55.25 US$79,777
2015-05-21 2015-05-19
US Abbvie Inc (ABBV)
S Sale
6,200 -8.3%
66.00
US$409,200 		6,200 -8.3% 66.00 US$409,200
2015-03-03 2015-02-27
US Abbvie Inc (ABBV)
S Sale
1,185 -1.7%
60.57
US$71,777 		1,185 -1.7% 60.57 US$71,777
2014-11-26 2014-11-24
US Abbvie Inc (ABBV)
S Sale
100 -0.2%
67.82
US$6,782 		100 -0.2% 67.82 US$6,782
2014-11-26 2014-11-24
US Abbvie Inc (ABBV)
S Sale
1,400 -2.2%
67.81
US$94,936 		1,400 -2.2% 67.81 US$94,936